N Harbeck Selected Research

N Harbeck Research Topics

Disease

80	Breast Neoplasms (Breast Cancer) 03/2022 - 01/2000
41	Neoplasms (Cancer) 01/2022 - 01/2000
14	Neoplasm Metastasis (Metastasis) 03/2016 - 01/2000
5	Carcinoma (Carcinomatosis) 09/2003 - 01/2001
4	Pain (Aches) 04/2020 - 01/2016
3	Neutropenia 01/2018 - 09/2015
2	Arthralgia (Joint Pain) 04/2020 - 02/2014
2	Disease Progression 01/2018 - 01/2016
2	Triple Negative Breast Neoplasms 01/2017 - 12/2009
2	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2017 - 07/2007
2	Ovarian Neoplasms (Ovarian Cancer) 08/2011 - 04/2011
2	Cardiotoxicity 04/2009 - 05/2004
1	Myalgia 04/2020
1	Musculoskeletal Pain 04/2020
1	Febrile Neutropenia 09/2017
1	Residual Neoplasm 01/2017
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2017
1	Unilateral Breast Neoplasms 10/2016
1	Obesity 06/2015
1	Chronic Disease (Chronic Diseases) 02/2013

Drug/Important Bio-Agent (IBA)

18	Hormones (Hormone)IBA 12/2021 - 02/2001
15	Plasminogen Activator Inhibitor 1IBA 05/2013 - 01/2000
12	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2017 - 01/2000
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2000
8	Letrozole (Femara)FDA LinkGeneric 04/2020 - 12/2008
7	Trastuzumab (Herceptin)FDA Link 03/2022 - 05/2004
7	AntigensIBA 08/2011 - 01/2000
6	Progesterone Receptors (Progesterone Receptor)IBA 12/2021 - 01/2000
6	Docetaxel (Taxotere)FDA Link 09/2017 - 09/2006
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2017 - 05/2004
6	Plasminogen Activators (Plasminogen Activator)IBA 01/2017 - 07/2001
6	Epirubicin (Ellence)FDA LinkGeneric 06/2015 - 05/2004
5	Estrogen ReceptorsIBA 12/2021 - 01/2016
5	AnthracyclinesIBA 01/2013 - 12/2004
5	Proteins (Proteins, Gene)FDA Link 04/2011 - 01/2000
5	Biological FactorsIBA 10/2010 - 01/2000
4	Paclitaxel (Taxol)FDA LinkGeneric 03/2022 - 09/2011
4	Glycoproteins (Glycoprotein)IBA 09/2001 - 03/2000
3	Fulvestrant (Faslodex)FDA Link 01/2021 - 09/2009
3	Aromatase InhibitorsIBA 04/2020 - 06/2013
3	Phenobarbital (Luminal)FDA Link 06/2019 - 02/2013
3	palbociclibIBA 04/2019 - 01/2016
3	Biosimilar PharmaceuticalsIBA 01/2018 - 09/2015
3	Pharmaceutical PreparationsIBA 01/2017 - 06/2011
3	taxaneIBA 04/2016 - 01/2013
3	N,N'-bis(4-azidobenzoyl)cystineIBA 02/2016 - 10/2014
3	Darbepoetin alfa (Aranesp)FDA Link 01/2014 - 09/2011
3	Serine Proteases (Serine Protease)IBA 04/2011 - 01/2000
3	Estrogens (Estrogen)FDA Link 12/2009 - 01/2000
3	Monoclonal AntibodiesIBA 09/2001 - 02/2001
3	Messenger RNA (mRNA)IBA 02/2001 - 01/2000
2	pertuzumabIBA 03/2022 - 11/2017
2	abemaciclibIBA 01/2022 - 12/2021
2	ErbB Receptors (EGF Receptor)IBA 12/2021 - 04/2019
2	Filgrastim (Neupogen)FDA Link 01/2018 - 09/2015
2	Diphosphonates (Bisphosphonates)IBA 01/2017 - 03/2016
2	Tumor Biomarkers (Tumor Markers)IBA 01/2017 - 08/2011
2	Anastrozole (Arimidex)FDA LinkGeneric 02/2014 - 06/2013
2	Peptide Hydrolases (Proteases)FDA Link 08/2011 - 04/2011
2	Tamoxifen FDA LinkGeneric 12/2010 - 12/2008
2	Cathepsin BIBA 11/2004 - 01/2000
2	Urokinase Plasminogen Activator ReceptorsIBA 11/2004 - 10/2000
2	Taxoids (Taxanes)IBA 12/2003 - 09/2003
2	SteroidsIBA 10/2003 - 02/2001
2	Biological ProductsIBA 09/2003 - 06/2003
2	CathepsinsIBA 09/2001 - 01/2000
2	Cell Surface ReceptorsIBA 07/2001 - 06/2001
2	Plasminogen InactivatorsIBA 06/2001 - 01/2000
2	Tissue ExtractsIBA 06/2001 - 10/2000
2	RNA (Ribonucleic Acid)IBA 02/2001 - 06/2000
2	AntibodiesIBA 10/2000 - 01/2000
1	2- (3- (2- (1- isopropyl- 3- methyl- 1H- 1,2- 4- triazol- 5- yl)- 5,6- dihydrobenzo(f)imidazo(1,2- d)(1,4)oxazepin- 9- yl)- 1H- pyrazol- 1- yl)- 2- methylpropanamideIBA 01/2021
1	Carboplatin (JM8)FDA LinkGeneric 01/2018
1	Gemcitabine FDA Link 01/2018
1	130-nm albumin-bound paclitaxelIBA 01/2018
1	pegfilgrastim (Neulasta)FDA Link 09/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2017
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 09/2017
1	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 01/2017
1	Clodronic Acid (Clodronate)IBA 03/2016
1	Zoledronic Acid (Zometa)FDA Link 03/2016
1	EnzymesIBA 08/2011
1	ImmunosorbentsIBA 08/2011
1	Tissue Kallikreins (Tissue Kallikrein)IBA 08/2011
1	Kallikreins (Kallikrein)IBA 04/2011
1	exemestane (Aromasin)FDA Link 12/2010

Therapy/Procedure

44	Therapeutics 01/2022 - 01/2000
25	Drug Therapy (Chemotherapy) 01/2018 - 01/2000
10	Adjuvant Chemotherapy 04/2016 - 01/2000
2	Precision Medicine 01/2022 - 02/2013
2	Secondary Prevention 01/2018 - 01/2018
2	Neoadjuvant Therapy 01/2017 - 09/2011
2	Adjuvant Radiotherapy 10/2016 - 11/2015
2	Radiotherapy 10/2016 - 05/2006
2	Segmental Mastectomy (Lumpectomy) 10/2016 - 11/2015
2	Combination Drug Therapy (Combination Chemotherapy) 04/2009 - 06/2001
1	Complementary Therapies (Alternative Medicine) 04/2020
1	Withholding Treatment 01/2018
1	Immunotherapy 01/2017
1	Palliative Care (Palliative Therapy) 12/2014